SCHEMBL13719346

SCHEMBL13719346

CC(C)Cc1cccc(Oc2ccc(C(C)(C)C)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDFT1 P37268 3/20 0.50
▸ CETP P11597 1/20 0.46
▸ FAAH O00519 1/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TAAR1 Q96RJ0 2/20 0.44
▸ EPOR P19235 1/20 0.42
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ADAMTS5 Q9UNA0 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9538055 0.85 TAAR1 (0.56) FDFT1CETPALDH1A1TAAR1PPARG
SCHEMBL8174800 0.84 CETP (0.54) FDFT1CETPALDH1A1TAAR1PPARG
SCHEMBL16316303 0.83 FDFT1 (0.50) FDFT1FAAHNPC1RAB9AALDH1A1
SCHEMBL13718948 0.83 FFAR1 (0.48) FDFT1CETPFAAHALDH1A1TAAR1
SCHEMBL13718930 0.83 TAAR1 (0.60) CETPALDH1A1TAAR1PPARGPPARA
SCHEMBL13719088 0.81 PPARG (0.59) FDFT1CETPALDH1A1TAAR1PPARG
SCHEMBL8171976 0.81 CETP (0.47) FDFT1CETPALDH1A1MAPTHPGD
SCHEMBL13802648 0.81 FAAH (0.49) FDFT1FAAHNPC1RAB9AALDH1A1
SCHEMBL4178681 0.81 ALDH1A1 (0.51) FDFT1FAAHNPC1RAB9AALDH1A1
SCHEMBL4178678 0.81 FDFT1 (0.49) FDFT1FAAHNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579479-B2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-25 — — US disclosed
US-7241780-B2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method BRISTOLS-MYERS SQUIBB COMPANY (US) 2007-07-10 — — US disclosed
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method CHENG PETER T 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method GPR119, LIPC, ACACA FDFT1 1139/4885CETP 225/4885FAAH 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback